There is a significant body of evidence documenting the important contribution by circulating and tumour-infiltrating T effector (CD4+ and CD8+) and regulatory (FOXP3+ and CTLA-4+) cells and NK cells in immune-mediated breast cancer cell death in women with LLABCs undergoing NAC. This evidence concerns the gene CD4 and neoplasm.